Bioz is the world’s most advanced AI search engine for life science experimentation, empowering scientists in biopharma and academia to accelerate their research towards new discoveries. Bioz guides scientists to the most-validated and cost-effective products to use in their experiments by providing them with evidence-based product recommendations. These recommendations have been reverse-engineered from real-world experiments, as described in over 500 million pages of scientific text from peer-reviewed articles. The result: Bioz.com, the world’s most comprehensive source of life science product recommendations and experimentation guidance, covering over 300 million products, 50,000 suppliers, 16 million images, and over 7 billion protocol conditions and associated techniques, enabling researchers to work faster and more cost-effectively, generating more successful and impactful outcomes. Bioz AI was developed by an experienced team of software engineers, led by AI experts from Microsoft and Google and Nobel Prize winners in chemistry. The technology incorporates proprietary cutting-edge NLP, ML, neural networks, deep learning, and domain-specific named-entity recognition, entity matching, and entity linking algorithms. What used to take scientists months, now takes them mere minutes with Bioz, 84x times faster than before. By accelerating the pace of experiments, Bioz increases the speed of drug discovery by as much as 56%, which translates into billions of research dollars saved. With objectivity, transparency, and trustworthiness, Bioz empowers researchers in the top 25 biopharma companies, and in more than 12,400 academic institutions in 196 countries.
-
Industry
-
Software Development
-
Company size
-
11-50 employees
-
Headquarters
-
Palo Alto, California
-
Type
-
Privately Held
-
Founded
-
2013
-
Specialties
-
Software, Life Science, Natural Language Processing, Machine Learning, Search Engine, Researcher Collaboration, Biology Experimentation, Artificial Intelligence, PubMed, Science, Life Science Tools, Search, Biopharma, IT, and AI